Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

5% minoxidil foam effectively treats female hair loss.

New psoriasis treatments are effective but come with side effects and risks.

Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.

Natural products show promise for new hair loss treatments.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Finasteride has various adverse effects, including sexual dysfunction and mental health issues, which vary by age and gender.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

PRP treatments for hair loss need standard protocols to be reliable.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Synthetic hair fibers for hair restoration were controversial in 2009 due to health risks and lack of support from the International Society of Hair Restoration.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

The article concludes that products can affect the body without being drugs as long as they don't claim to treat or prevent diseases, except for cosmetic sunscreens.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

A blood pressure drug, diltiazem, may also help treat influenza.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.